EPIQ Capital Group’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,889
Closed -$199K 68
2024
Q1
$199K Hold
12,889
0.08% 60
2023
Q4
$115K Hold
12,889
0.05% 55
2023
Q3
$81.1K Hold
12,889
0.04% 53
2023
Q2
$121K Hold
12,889
0.06% 51
2023
Q1
$128K Hold
12,889
0.06% 50
2022
Q4
$82.6K Hold
12,889
0.05% 46
2022
Q3
$72K Hold
12,889
0.04% 46
2022
Q2
$58K Sell
12,889
-922
-7% -$3.93K 0.02% 43
2022
Q1
$74K Sell
13,811
-4,603
-25% -$22.8K 0.02% 51
2021
Q4
$121K Buy
+18,414
New +$133K 0.02% 55

Other funds holding HIMS

EPIQ Capital Group's HIMS Position: Q2 2024 in Review

EPIQ Capital Group sold out of Hims & Hers Health (HIMS) in Q2 2024, closing a stake of 12,889 shares — an estimated $199K sold.

EPIQ Capital Group first reported a position in HIMS in Q4 2021 and held it in 10 quarters. The position peaked at $199K in Q1 2024. 297 funds tracked by Wall St. Rank hold HIMS as of Q2 2024.

  • EPIQ Capital Group reported no remaining Hims & Hers Health position as of Q2 2024 after selling out during the quarter.
  • EPIQ Capital Group sold 12,889 Hims & Hers Health shares in Q2 2024, an estimated $199K.
  • EPIQ Capital Group first reported a position in Hims & Hers Health in Q4 2021 and held it in 10 quarters.
  • EPIQ Capital Group's Hims & Hers Health position peaked at $199K in Q1 2024.
  • 297 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2024.

Based on EPIQ Capital Group's 13F filing for Q2 2024, filed 9 Aug 2024.